Andrew Klips

Actionable insights straight to your inbox

Andrew Klips became enraptured with the markets as a teenager and has been an active trader on a daily basis for more than a decade. Specializing in technical analysis, he is an avid player of stock charts making technical bottoms mixed with a particular affinity for the fundamentals of biotechnology companies.

Hodgepodge of Housing Data an Anchor on Builders in July

The lull at the start of 2014 for the housing market that was blamed on unseasonably cold and icy weather has not bounced back the way many analysts expected, lending to a mixed bag of housing

3 MIN READ
07/29/2014

SiriusXM Hits Record Number of Subscribers in Q2, Profits Slip

More subscribers led to more net revenue for SiriusXM Holdings Inc. (SIRI) , which helped mediate a 4.4 percent decline in profit during the second quarter on the back of higher operating

3 MIN READ
07/29/2014

More Tax Inversions: Abbott Selling Part of Generic Drug Business to Mylan for $5.3 Billion

After failing to ink a deal to acquire Swedish drug maker Meda in April, generic pharmaceutical company Mylan, Inc. (MYL) got its way to move its headquarters overseas, a move called a “tax

3 MIN READ
07/14/2014

Andrew Klips

Hodgepodge of Housing Data an Anchor on Builders in July

SiriusXM Hits Record Number of Subscribers in Q2, Profits Slip

More Tax Inversions: Abbott Selling Part of Generic Drug Business to Mylan for $5.3 Billion

Sign up For our Newsletter

SITEMAP

Contact